echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimers Dementia: What are the characteristics of dementia-related medical expenditures?

    Alzheimers Dementia: What are the characteristics of dementia-related medical expenditures?

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Currently, more than 6 million adults in the United States have Alzheimer's disease and related dementia (ADRD)
    .


    Current estimates suggest that the cost of ADRD is Medicare (Parts A and B) ranging from $3,019 to $10,598 per person per year (2017 dollars)


    Medicaid, the public insurance program for low-income people and the primary payer of long-term care in the U.
    S.
    , is often overlooked for its costs
    .


    Because ADRD is characterized by cognitive impairment that results in difficulties with daily activities, the cost of long-term care can be considerable


    Four reports estimated the cost of Medicaid nationwide, relying on self-reported usage and imputed Medicaid spending
    .


    Medicare and Medicaid


    Apart from the incompleteness of estimated costs, the literature has largely focused on estimating costs based on prevalent cases
    .


    Popular cost estimates are useful for understanding current expenditures, but have limited use in predicting future costs if the case mix is ​​changing, or if the cost of the disease changes over the course of the disease


    The incidence of ADRD is declining in high-income countries, leading to changes in the case mix, and there is evidence that dementia-related costs vary widely depending on the time since diagnosis or the time before death
    .

    diagnosis

    From this, Norma B.
    Coe et al.
    of the University of Pennsylvania estimated the incremental cost of ADRD to public finances in the first 5 years after diagnosis through Medicare (Parts A, B, and D) and Medicaid
    .

    They estimated total spending and spending by cost component (inpatients, prescription drugs, nursing home and home health care, and others) to see which usage was driving costs
    .

    Using data from the Health and Retirement Study matched to Medicare and Medicaid reimbursement, they identified a retrospective cohort of adults with reimbursement-based ADRD diagnoses, as well as matched controls
    .

    In the first 5 years after diagnosis, ADRD cost per dementia case was $15,632 and Medicaid was $8,833
    .

    In the first 5 years after diagnosis, ADRD cost per dementia case was $15,632 and Medicaid was $8,833
    .


    70% of Medicare costs are incurred in the first two years; Medicaid costs are concentrated on longer-lived beneficiaries who are more likely to need long-term care and be covered by Medicaid
    .

    Medium implications of this study: Since the distribution of incremental costs varies over time and insurance programs , when an intervention occurs, and how it affects the disease process, will have an impact on how much and which program gets the benefit
    .

    Because the distribution of incremental costs varies over time and insurance program


    Source:
    Coe NB, White L, Oney M, Basu A, Larson EB.


    Public spending on acute and long‐term care for Alzheimer's disease and related dementias.
    Alzheimer's & Dementia.


    Public spending on acute and long‐term care for Alzheimer's disease and related dementias.
    Alzheimer's & Dementia.
    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.